Sesgos en el estudio de los factores pronósticos;Bias in studies of prognostic factors

Medicina Clinica

Volumn 112, Issue SUPPL. 1, 1999, Pages 51-58

  Delgado Rodríguez, Miguel ^a  

^a UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDEMIOLOGY; FACTUAL DATABASE; FOLLOW UP; HUMAN; PATIENT COMPLIANCE; PATIENT SELECTION; PROGNOSIS; REPRODUCIBILITY; REVIEW; TREATMENT REFUSAL;

BIAS (EPIDEMIOLOGY); DATABASES, FACTUAL; FOLLOW-UP STUDIES; HUMANS; PATIENT COMPLIANCE; PATIENT SELECTION; PROGNOSIS; REPRODUCIBILITY OF RESULTS; TREATMENT REFUSAL;

EID: 0040812938     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Simon R, Altman DG. Statistical aspects of prognostic factors studies in oncology. Br J Cancer 1994; 69: 979-985.
2. Sackett DL, Richardson WS, Rosenberg W, Haynes RB. Evidence-based medicine. Nueva York: Churchill Livingstone, 1997.
3. Sackett DL, Whelan G. Cancer risk in ulcerative colitis: scientific requirements for the study of prognosis. Gastroenterology 1980; 78: 1.632-1.635.
4. Greenstein AJ, Sachar DB, Pucillo A. Cancer in universal and left-sided ulcerative colitis: factors-determining risk. Gastroenterology 1979; 77: 290-294.
5. Tüchsen F, Andersen O, Olsen J. Referral bias among health workers in studies using hospitalization as a proxy measure of the underlying incidence rate. J Clin Epidemiol 1996; 49: 791-794.
6. Melton JL III, Dyck PJ, Karnes JL, O'Brien PC, Service FJ. Non-response bias in studies of diabetic complications: the Rochester diabetic neuropathy study. J Clin Epidemiol 1993; 46: 341-348.
7. Medical Research Council Antiepileptic Drug Withdrawal Study Group. Prognostic index for recurrence of seizures after remission of epilepsy. Br Med J 1993; 306: 1.374-1.378.
8. Sackett DL. Bias in analytic research. J Chron Dis 1979; 32: 51-63.
9. Simon R. Length biased sampling in etiologic studies. Am J Epidemiol 1980; 111: 444-452.
10. Pinski SL, Maloney JD, Sgarbossa EB, Trohman RG. Selection bias in electrophysiologically-guided therapy of sustained ventricular tachyarrhythmias. J Clin Epidemiol 1994; 47: 49-57.
11. Glesby MJ, Hoover DR. Survivor treatment selection bias in observational studies: examples from the AIDS literature. Ann Intern Med 1996; 124: 999-1.005.
12. Robins JM, Blevins D, Ritter G, Wulfsohn M. G-estimation of the effect of prophylaxis therapy for Pneumocystis carinii pneumonia on the survival of AIDS patients. Epidemiology 1992; 3: 319-336.
13. Infante-Rivard C, Villeneuve J-P, Esnaola S. A framework for evaluating and conducting prognostic studies: an application to cirrhosis of liver. J Clin Epidemiol 1989; 42: 791-805.
14. Castellanos Ortega A. Estudio de factores pronósticos del shock tóxico infantil asociado a púrpura [tesis doctoral], Santander: Universidad de Cantabria, 1998.
15. Laupacis A, Wells G, Richardson S, Tugwell P, for the Evidence-based medicine working group. Users' guides to medical literature. V. How to use an article about prognosis. JAMA 1994; 272: 234-237.
16. Buyse M, Piedbois P. On the relationship between response to treatment and survival time. Stat Med 1996; 15: 2.797-2.812.
17. Greenland S. The effect of misclassification in the presence of covariates. Am J Epidemiol 1980; 112: 564-569.
18. Dosemeci M, Wacholder S, Lubin JH. Does nondifferential misclassification of exposure always bias a true effect toward the null value. Am J Epidemiol 1990; 132: 746-748.
19. Wacholder S, Dosemeci M, Lubin JH. Blind assessment of exposure does not always prevent differential misclassification. Am J Epidemiol 1991; 134: 433-437.
20. Feinstein AR, Sosin DM, Wells CK. The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. N Engl J Med 1985; 312: 1.604-1.608.
21. Farrow DC, Hunt WC, Samet JM. Biased comparisons of lung cancer survival across geographic areas: effect of stage bias. Epidemiology 1995; 6: 558-560.
22. Tierney WM, McDonald CJ. Practice databases and their uses in clinical research. Stat Med 1991; 10: 541-557.
23. Moses LE. Innovative methodologies for research using databases. Stat Med 1991; 10: 629-633.
24. Califf RM, Pryor DB, Greenfield JC. Beyond randomized clinical trials: applying clinical experience in the treatment of patients with coronary artery disease. Circulation 1986; 74: 1.191-1.194.
25. Safran C. Using routinely collected data for clinical research. Stat Med 1991; 10: 559-564.
26. Rothman KJ. Modern Epidemiology. Boston: Little, Brown & Co., 1986.
27. Byar DP. Problems with using observational databases to compare treatments. Stat Med 1991; 10: 663-666.
28. Seagroatt V. Mortality after prostatectomy: selection and surgical approach. Lancet 1995; 346: 1.521-1.524.
29. Latour J, López V, Rodríguez M, Nolasco A, Alvarez-Dardet C. Inequalities in health in intensive care patients. J Clin Epidemiol 1991; 44: 889-894.
30. Auvinen A, Karjalainen S, Pukkala E. Social class and cancer patient survival in Finland. Am J Epidemiol 1995; 142: 1.089-1.102.
31. Schrijvers CTM, Mackenbach JP, Lutz J-M, Quinn MJ, Coleman MP. Deprivation, stage at diagnosis and cancer survival. Int J Cancer 1995; 63: 324-329.
32. Kaplan GA, Keil JE. Socioeconomic factors and cardiovascular disease: a review of the literature. Circulation 1993; 88: 1.973-1.998.
33. a ed.). Nueva York: Oxford University Press, 1991; 2: 268.
34. Altman DG, De Stavola BL, Love SB, Stepniewska KA. Review of survival analyses published in cancer journal. Br J Cancer 1995; 72; 511-518.
35. Pryor DB, Lee KL. Methods for the analysis and assessment of clinical databases: the clinicians perspective. Stat Med 1991; 10: 617-628.